Please assess the completion status of the following clinical trial:

Trial Title: Food Reward in Cachexia Induced by Acute or Chronic Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* For cachectic patients: weight loss exceeds 5% of total body weight over the past 6 months, or \>2% when body mass index is \<20 kg/m2~* For non-cachectic patients: no weight loss of ≥5% during the last 6 months~* Non-small cell lung cancer or gastro-intestinal cancer, pathology proven or diagnosis of COPD consistent with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria~Exclusion Criteria:~* Contra-indications for fMRI examination (operation to your head or brain in the past; implanted electronic devices, for instance a pacemaker, neurostimulator, cochlear or hearing implant; insulin pump under your skin; Pregnant subjects, claustrophobia; pregnancy; metal parts in your body (except from teeth filling and connectors): implants; brain vessel clamps, prostheses, intra-uterine device, metal splinter in the eye, metal braces or other metal objects, permanent eye make-up)~* Psychiatric or other disorders likely to impact on informed consent~* Presence of brain metastasis (screening is not mandatory)~* Medical history of cerebrovascular accident, brain tumour, brain metastasis~* Previous radiotherapy to brain, both stereotactic and whole brain radiotherapy~* Memory problems~* Current use of tube feeding or parental nutrition~* Patients with an active second malignancy~* Patients unable to lie still for 2 hours~* Unable to complete the cognitive task~* Pre-existing swallowing difficulties~* Allergy to gluten-, milk- or wheat products~* Self-reported hyperthyroidism~* Self-reported diabetes mellitus~* Current use of appetite stimulant medications

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cachectic cancer patients (Type: None): Cachectic cancer patients, including non-small cell lung cancer (NSCLC) and gastro-intestinal cancer. The study participants will undergo fMRI scanning.
- Non-cachectic cancer patients (Type: None): Non-cachectic cancer patients, including NSCLC and gastro-intestinal cancer. The study participants will undergo Functional magnetic resonance imaging (fMRI) scanning.
- Cachectic COPD patients (Type: None): Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) consistent with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. The study participants will undergo fMRI scanning.
- Non-cachectic COPD patients (Type: None): Diagnosis of COPD consistent with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria. The study participants will undergo fMRI scanning.

Based on this trial design, predict the completion outcome and termination type (if applicable).